Effects of Intracerebroventricularly (ICV) Injected Ghrelin on Cardiac Inducible Nitric Oxide Synthase Activity/Expression in Obese Rats

Experimental and Clinical Endocrinology and Diabetes

Volumn 123, Issue 10, 2015, Pages 581-588

  Sudar Milovanovic, E ^a   Jovanovic, A ^a   Misirkic Marjanovic, M ^b   Vucicevic, Lj ^b   Janjetovic, K ^b   Isenovic, E R ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

extracellular signal regulated kinases 1 2; ghrelin; heart; nitric oxide; nitric oxide synthase; protein kinase B

Indexed keywords

GHRELIN; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NITRIC OXIDE; PROTEIN KINASE B; TRANSCRIPTION FACTOR RELA; FAT INTAKE; NOS2 PROTEIN, RAT; RELA PROTEIN, RAT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CARDIAC MUSCLE; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; FAT INTAKE; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; PHARMACOLOGY; WISTAR RAT;

ANIMALS; DIETARY FATS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GHRELIN; MALE; MAP KINASE SIGNALING SYSTEM; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE II; OBESITY; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; TRANSCRIPTION FACTOR RELA;

EID: 84948184682     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0035-1559758     Document Type: Article

References (63)

1. Kojima M., Kangawa K. Ghrelin: structure and function. Physiol Rev: 2005; 85 495 522
2. Korbonits M., Goldstone A. P., Gueorguiev M. et al. Ghrelin - a hormone with multiple functions. Front Neuroendocrinol: 2004; 25 27 68
3. Pulkkinen L., Ukkola O., Kolehmainen M. et al. Ghrelin in diabetes and metabolic syndrome. Int J Pept: 2010; 2010
4. Sudar E., Dobutovic B., Soskic S. et al. Regulation of inducible nitric oxide synthase activity/expression in rat hearts from ghrelin-treated rats. J Physiol Biochem: 2011; 67 195 204
5. Zhang G., Yin X., Qi Y. et al. Ghrelin and cardiovascular diseases. Curr Cardiol Rev: 2010; 6 62 70
6. Tesauro M., Schinzari F., Iantorno M. et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation: 2005; 112 2986 2992
7. Wang Y., Narsinh K., Zhao L. et al. Effects and mechanisms of ghrelin on cardiac microvascular endothelial cells in rats. Cell Biol Int: 2011; 35 135 140
8. Matsumura K., Tsuchihashi T., Fujii K. et al. Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension: 2002; 40 694 699
9. Okumura H., Nagaya N., Enomoto M. et al. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol: 2002; 39 779 783
10. Xie Q., Nathan C. The high-output nitric oxide pathway: role and regulation. J Leukoc Biol: 1994; 56 576 582
11. Balligand J. L., Cannon P. J. Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences. Arterioscler Thromb Vasc Biol: 1997; 17 1846 1858
12. Iantorno M., Chen H., Kim J. A. et al. Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells. Am J Physiol Endocrinol Metab: 2007; 292 E756 E764
13. Isenovic E., LaPointe M. C. Role of Ca(2+)-independent phospholipase A(2) in the regulation of inducible nitric oxide synthase in cardiac myocytes. Hypertension: 2000; 35 249 254
14. Isenovic E., Walsh M. F., Muniyappa R. et al. Phosphatidylinositol 3-kinase may mediate isoproterenol-induced vascular relaxation in part through nitric oxide production. Metabolism: 2002; 51 380 386
15. Kim J. A., Montagnani M., Koh K. K. et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation: 2006; 113 1888 1904
16. Strijdom H., Friedrich S. O., Hattingh S. et al. Hypoxia-induced regulation of nitric oxide synthase in cardiac endothelial cells and myocytes and the role of the PI3-K/PKB pathway. Mol Cell Biochem: 2009; 321 23 35
17. Rao K. M. Molecular mechanisms regulating iNOS expression in various cell types. J Toxicol Environ Health B. Crit Rev: 2000; 3 27 58
18. Dimmeler S., Fleming I., Fisslthaler B. et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature: 1999; 399 601 605
19. Buettner R., Scholmerich J., Bollheimer L. C. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring): 2007; 15 798 808
20. Starcevic V. P., Morrow B. A., Farner L. A. et al. Long-term recording of cerebrospinal fluid pressure in freely behaving rats. Brain Res: 1988; 462 112 117
21. Stevanovic D., Nesic D., Milosevic V. et al. Consummatory behavior and metabolic indicators after central ghrelin injections in rats. Regul Pept: 2008; 147 52 59
22. Stevanovic D., Starcevic V., Vilimanovich U. et al. Immunomodulatory actions of central ghrelin in diet-induced energy imbalance. Brain Behav Immun: 2012; 26 150 158
23. Shimizu Y., Nagaya N., Teranishi Y. et al. Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochem Biophys Res Commun: 2003; 310 830 835
24. Matthews D. R., Hosker J. P., Rudenski A. S. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia: 1985; 28 412 419
25. Hevel J. M., Marletta M. A. Nitric-oxide synthase assays. Methods Enzymol: 1994; 233 250 258
26. Corraliza I. M., Campo M. L., Soler G. et al. Determination of arginase activity in macrophages: a micromethod. J Immunol Methods: 1994; 174 231 235
27. Boyde T. R., Rahmatullah M. Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime. Anal Biochem: 1980; 107 424 431
28. Fearon W. R. The carbamido diacetyl reaction: a test for citrulline. Biochem J: 1939; 33 902 907
29. Sudar E., Dobutovic B., Milosavljevic T. et al. Interactive effects of insulin and β-estradiol on protein kinase b phosphorylation in adult rat cardiomyocytes. Acta Chimica Slovenica: 2009; 56 723 728
30. Livak K. J., Schmittgen T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods: 2001; 25 402 408
31. Hou C. H., Lin J., Huang S. C. et al. Ultrasound stimulates NF-kappaB activation and iNOS expression via the Ras/Raf/MEK/ERK signaling pathway in cultured preosteoblasts. J Cell Physiol: 2009; 220 196 203
32. Nathan C., Xie Q. W. Regulation of biosynthesis of nitric oxide. J Biol Chem: 1994; 269 13725 1378
33. Dobutovic B., Sudar E., Tepavcevic S. et al. Effects of ghrelin on protein expression of antioxidative enzymes and iNOS in the rat liver. Arch Med Sci: 2014; 10 806 816
34. Barnard R. J., Roberts C. K., Varon S. M. et al. Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. J Appl Physiol (1985): 1998; 84 1311 1315
35. Reil T. D., Barnard R. J., Kashyap V. S. et al. Diet-induced changes in endothelial-dependent relaxation of the rat aorta. J Surg Res: 1999; 85 96 100
36. Obradovic M., Sudar E., Zafirovic S. et al. Estradiol In Vivo Induces Changes in Cardiomyocytes Size in Obese Rats. Angiology: 2015; 66 25 35
37. Nakazato M., Murakami N., Date Y. et al. A role for ghrelin in the central regulation of feeding. Nature: 2001; 409 194 198
38. Tschop M., Smiley D. L., Heiman M. L. Ghrelin induces adiposity in rodents. Nature: 2000; 407 908 913
39. Wan G., Ohnomi S., Kato N. Increased hepatic activity of inducible nitric oxide synthase in rats fed on a high-fat diet. Biosci Biotechnol Biochem: 2000; 64 555 561
40. Jia Y. X., Pan C. S., Yang J. H. et al. Altered L-arginine/nitric oxide synthase/nitric oxide pathway in the vascular adventitia of rats with sepsis. Clin Exp Pharmacol Physiol: 2006; 33 1202 1208
41. Morris S. M. Jr. Arginine metabolism in vascular biology and disease. Vasc Med: 2005; 10 01 S83 S87
42. Wu G., Morris S. M. Jr. Arginine metabolism: nitric oxide and beyond. Biochem J: 1998; 336 1 17
43. Zhao D., Zhan Y., Zeng H. et al. Ghrelin stimulates interleukin-8 gene expression through protein kinase C-mediated NF-kappaB pathway in human colonic epithelial cells. J Cell Biochem: 2006; 97 1317 1327
44. Lowenstein C. J. NO news is good news. Proc Natl Acad Sci USA: 1999; 96 10953 10954
45. Maulik N., Sato M., Price B. D. et al. An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett: 1998; 429 365 369
46. Baldanzi G., Filigheddu N., Cutrupi S. et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol: 2002; 159 1029 1037
47. Chung H., Seo S., Moon M. et al. Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells. J Endocrinol: 2008; 198 511 521
48. Granata R., Settanni F., Biancone L. et al. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3′,5′-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling. Endocrinology: 2007; 148 512 529
49. Kim J. W., Kim C. Inhibition of LPS-induced NO production by taurine chloramine in macrophages is mediated though Ras-ERK-NF-kappaB. Biochem Pharmacol: 2005; 70 1352 1360
50. Ellerhorst J. A., Ekmekcioglu S., Johnson M. K. et al. Regulation of iNOS by the p44/42 mitogen-activated protein kinase pathway in human melanoma. Oncogene: 2006; 25 3956 3962
51. Xiao Z., Wang T., Qin H. et al. Endoplasmic reticulum Ca2+release modulates endothelial nitric-oxide synthase via extracellular signal-regulated kinase (ERK) 1/2-mediated serine 635 phosphorylation. J Biol Chem: 2011; 286 20100 20108
52. Ahmed K. M., Dong S., Fan M. et al. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells. Mol Cancer Res: 2006; 4 945 955
53. Nagaya N., Uematsu M., Kojima M. et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation: 2001; 104 1430 1435
54. Volterrani M., Manelli F., Cicoira M. et al. Role of growth hormone in chronic heart failure. Therapeutic implications. Drugs: 2000; 60 711 719
55. Hasdai D., Rizza R. A., Holmes D. R. Jr. et al. Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro. Hypertension: 1998; 32 228 234
56. Walsh M. F., Barazi M., Pete G. et al. Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology: 1996; 137 1798 1803
57. Isenovic E. R., Divald A., Milivojevic N. et al. Interactive effects of insulin-like growth factor-1 and beta-estradiol on endothelial nitric oxide synthase activity in rat aortic endothelial cells. Metabolism: 2003; 52 482 487
58. Boger R. H., Bode-Boger S. M., Frolich J. C. The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications. Atherosclerosis: 1996; 127 1 11
59. Stevanovic D., Milosevic V., Nesic D. et al. Central effects of ghrelin on serum growth hormone and morphology of pituitary somatotropes in rats. Exp Biol Med (Maywood): 2006; 231 1610 1615
60. Dembinski A., Warzecha Z., Ceranowicz P. et al. Variable effect of ghrelin administration on pancreatic development in young rats. Role of insulin-like growth factor-1. J Physiol Pharmacol: 2005; 56 555 570
61. Alvarez-Castro P., Isidro M. L., Garcia-Buela J. et al. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients. Clin Endocrinol (Oxf): 2004; 61 250 255
62. Hosoda H., Kangawa K. The autonomic nervous system regulates gastric ghrelin secretion in rats. Regul Pept: 2008; 146 12 18
63. Iwakura H., Akamizu T., Ariyasu H. et al. Effects of ghrelin administration on decreased growth hormone status in obese animals. Am J Physiol Endocrinol Metab: 2007; 293 E819 E825